Skye Bioscience Inc (SKYE)

[AntonChigurh]

Ingram is in for $2.50 a share, says Vinpat. With his own money.

Look up his history with Allergan and $VRX. He doesn't like getting taken out, and especially not buy bad people.

I don't see him taking to kind to a buy out unless it is at a premium to what he paid. although, Lykos and a few others are still the majority holders. I think it is more likely that one of the big boys (ZYNE, GW, INSYS) hit it big, and other banks start looking at the space more serious. More eyes on the sector, and NMUS will be able to get serious funding for their candidates.

Until then, were in survival mode while the company continues to do the little things right.

Capital is not going to be as efficient on the OTC as other markets. Patience will rewards us well with NMUS I think.